Archon Capital Management Updates Apyx Medical Stake

TL;DR

**Archon Capital Management still holds Apyx Medical shares, signaling continued institutional interest.**

AI Summary

Archon Capital Management LLC, a Washington-based investment firm, filed an amended SC 13G/A on February 13, 2024, indicating its ownership of Apyx Medical Corp (NASDAQ: APYX) common stock as of December 31, 2023. This filing updates their previous disclosures, showing their continued significant stake in the medical device company. This matters to investors because Archon Capital Management is a substantial institutional holder, and changes in their position can signal their confidence or concerns about Apyx Medical's future performance.

Why It Matters

This filing confirms Archon Capital Management's ongoing interest in Apyx Medical, providing transparency into a major institutional investor's position. It can influence investor sentiment and potentially the stock's perceived stability.

Risk Assessment

Risk Level: low — This is a routine amendment filing by an institutional investor, not indicating any immediate negative or positive event for the company.

Analyst Insight

Investors should note Archon Capital Management's continued presence as a significant shareholder, but this filing alone doesn't suggest a buy or sell action. It's a data point for understanding institutional interest.

Key Players & Entities

• Archon Capital Management LLC (company) — the reporting person and institutional investor
• Apyx Medical Corp (company) — the subject company whose stock is being reported
• December 31, 2023 (date) — the date of the event requiring this filing
• Washington (company) — state of organization for Archon Capital Management LLC

Forward-Looking Statements

• Archon Capital Management LLC will likely maintain a significant stake in Apyx Medical Corp for the foreseeable future. (Archon Capital Management LLC) — medium confidence, target: Q3 2024

FAQ

Key Financial Figures

• $0.001 — TION (Name of Issuer) Common Stock, $0.001 Par Value (Title of Class of Securiti

Filing Documents

• d10964219_13g-a.htm (SC 13G/A) — 120KB
• 0000919574-24-000911.txt ( ) — 122KB

From the Filing

SC 13G/A 1 d10964219_13g-a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 8)* APYX MEDICAL CORPORATION (Name of Issuer) Common Stock, $0.001 Par Value (Title of Class of Securities) 03837C106 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [_] Rule 13d-1(b) [X] Rule 13d-1(c) [_] Rule 13d-1(d) __________ *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes) CUSIP No 03837C106 1. NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Archon Capital Management LLC 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [_] (b) [_] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Washington NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 3,452,030 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 3,452,030 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 3,452,030 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [_] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 9.96% 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) OO, IA CUSIP No 03837C106 1. NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Constantinos Christofilis 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [_] (b) [_] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION United States NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 3,452,030 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 3,452,030 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 3,452,030 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [_] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 9.96% 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IN, HC CUSIP No 03837C106 1. NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Strategos Fund, L.P. 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [_] (b) [_] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 1,981,300 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 1,981,300 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,981,300 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [_] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.72% 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) PN CUSIP No 03837C106 Item 1. (a). Name of Issuer: APYX MEDICAL CORPORATION (b). Address of issuer’s principal executive offices: 5115 Ulmerton Road Clearwater, Florida 33760 Item 2. (a). Name of person filing: Archon Capital Management LLC Constantinos Christofilis Strategos Fund, L.P. (b). Address of principal business office, or if none, residence: Archon Capital Management LLC 1100 19 th Avenue E Seattle, Washington 98112 Constantinos Christofilis c/o Archon Capital Management LLC 1100 19 th Avenue E Seattle, Washington 98112 Strategos Fund, L.P. c/o Archon Capital Management LLC 1100 19 th Avenue E Seattle, Washington 98112 (c). Citizenship: Archon Capital Management LLC – Washington Constantinos Christofilis – United States Strategos Fund, L.P. – Delaware (d). Title of class of securities: Common Stock, $0.001 Par Value (e). CUSIP No.: 03837C106 Item 3. If this Statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b), or (c), check whether the person filing is a: (a) [_] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78c). (b) [_] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). (c) [_] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). (d) [

View Full Filing

View this SC 13G/A filing on SEC EDGAR